about
Modern Radiotherapy Concepts and the Impact of Radiation on Immune ActivationRadiation Metabolomics: Current Status and Future DirectionsRadio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical ApplicationsOn the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model.Hypofractionated stereotactic radiation therapy activates the peripheral immune response in operable stage I non-small-cell lung cancer.Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cellsThe MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1MiR-20a-5p promotes radio-resistance by targeting Rab27B in nasopharyngeal cancer cells.Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors.Release of monocyte migration signals by breast cancer cell lines after ablative and fractionated γ-irradiation.Integrative radiation systems biology.Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy.Radiation oncology: physics advances that minimize morbidity.Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo.Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines.Radiotherapy and immunotherapy: a beneficial liaison?Prior Radiotherapy Does Not Affect Abdominal Wall Reconstruction Outcomes: Evidence from Propensity Score Analysis.Tumor angiogenesis and vascular normalization: alternative therapeutic targets.MicroRNA-Target Network Inference and Local Network Enrichment Analysis Identify Two microRNA Clusters with Distinct Functions in Head and Neck Squamous Cell Carcinoma.microRNA-32 induces radioresistance by targeting DAB2IP and regulating autophagy in prostate cancer cells.Immunological aspects of radiotherapy.Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences.Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases.Host STING-dependent MDSC mobilization drives extrinsic radiation resistance.Tip60 is associated with resistance to X-ray irradiation in prostate cancer.Identification of Potential MR-Derived Biomarkers for Tumor Tissue Response to 177Lu-Octreotate Therapy in an Animal Model of Small Intestine Neuroendocrine Tumor.Cancer Cell Death-Inducing Radiotherapy: Impact on Local Tumour Control, Tumour Cell Proliferation and Induction of Systemic Anti-tumour Immunity.Metabolomics in Radiation-Induced Biological Dosimetry: A Mini-Review and a Polyamine Study.XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells
P2860
Q26744490-36790AF1-20A6-4912-A043-59D486863F89Q26766345-8B506DCD-0B63-4797-822D-9C1FCD288331Q26779221-4A6950AB-44F8-45F2-967E-67C3826DDE08Q31040893-76A77C8A-3513-449D-B6BF-C1DB1FA942D3Q33884923-7411F5C5-E05B-45AF-9198-274A2CABE044Q35761391-2DAE5B79-CE81-4C33-BDB6-F58ED6518483Q36380974-1F95E0E9-E43D-4955-BEE3-B6D385A6006BQ37590508-99D8443B-4153-4A29-9129-67F2D516786AQ37676791-BD684808-96FE-4025-B28D-8716B38DE3E5Q37685388-E0FAEBEA-82A5-4768-8B4F-944E0AFEE3DEQ37714614-822EEB16-D345-4D35-97C6-DF6610643E97Q38177390-F185883A-427C-4D92-A736-4FAE38F28124Q38217593-3C671FE5-2B2B-4FD1-B1EF-76355A4FFBFFQ38294588-9AB437B6-0079-4105-B47B-99DB495D6CCDQ38804738-34EB4427-9FC9-4426-B2DE-A277D2A8679BQ38868168-39CF05AE-EE9D-4FBE-B62D-63D50842097CQ39017268-F635B87F-4DED-4AAF-ACF5-ACE15995C1A5Q39328961-96B8225F-B189-400B-9965-7B52FA121EB2Q39403862-9E0DDC58-183E-449B-AF84-0EE46437B404Q40181079-869FB9E3-0E0F-4458-A52C-7A55D004E29DQ40257658-0A0C6667-4622-4B18-9D66-327B4B1A74A8Q42854786-FAE64809-6114-4E22-975F-76C74AD8A092Q47899811-129EEDD9-E2CA-49F4-8859-8B77CBD3623FQ48193685-70EBBC84-1984-43DC-963F-CF02ABA87070Q48245206-CB48E45A-F642-49E1-8335-57EA1F46E663Q50045723-504D0A72-B5E4-4EF5-B2A7-67AD1FFD2DEFQ50054742-F91E35F3-CD9D-48C7-A4C7-7DB8F30073C3Q51551651-344EACF9-25DC-4FBA-9529-67C851DD964FQ55438966-52619247-1576-40EA-B02B-2A6B4EA8055CQ58606469-4AEEEFEF-D3C0-4610-AA53-2D14C27F06AD
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current concepts in clinical radiation oncology.
@en
Current concepts in clinical radiation oncology.
@nl
type
label
Current concepts in clinical radiation oncology.
@en
Current concepts in clinical radiation oncology.
@nl
prefLabel
Current concepts in clinical radiation oncology.
@en
Current concepts in clinical radiation oncology.
@nl
P2093
P2860
P50
P1476
Current concepts in clinical radiation oncology.
@en
P2093
Anne Ernst
Claus Belka
Kirsten Lauber
Lars Schüttrumpf
Maximilian Niyazi
Minglun Li
Olivier M Niemöller
P2860
P2888
P356
10.1007/S00411-013-0497-2
P577
2013-10-20T00:00:00Z
2014-03-01T00:00:00Z